Formulation and Delivery - Chemical

(W0930-06-34) Ultraflexible Liposomes Enhance Topical Delivery of ADT-007 for Potential Melanoma Therapy

(M0930-06-35) Dissolving Microneedles Based on Carboxylmethylcellulose and Surfactant Systems for Enhanced Delivery of Itraconazole

(T0930-06-35) Feasibility and Application of Anti-Malarial Endoquine-Like Quinolone (ELQ) on Mosquito Bed Nettings and HDPE Films for Anti-Malarial Properties using Solution Coatings and Hot Melt Extrusion Methods

(W0930-06-35) Formulation and Development of Haloperidol Implants for Patients with Schizophrenia

(M0930-06-36) Development and Evaluation of Ribociclib-Loaded Folic Acid Conjugated Chitosan-Polycaprolactone Nanoparticles for the Management of Glioblastoma

(W0930-06-36) Pulmonary Delivery of Drug-Loaded Superparamagnetic Iron Oxide Nanoparticles for Diagnosis and Treatment of Tuberculosis

(W0930-06-37) Artificial Intelligence to Predict Drug Release from Sustained-Release Coated Tablets

(T0930-06-37) Developing Lipid Based Nano Drug Delivery System (LBNDDS) of Osimertinib in Combination with Curcumin Using Design of Experiment (DoE) for Enhanced Permeability and Release Effect

(M0930-06-37) Investigation of 3D Printed Structures Employing Triply Periodic Minimal Surface (TPMS) Topology for Poorly Soluble Drugs: Part I - Development of 3D-Printed Hypromellose Structure with Ibuprofen

(W0930-06-38) Optimized Platform-Based Formulation Strategies Can Accelerate Drug Development for Targeted Delivery: From Process Design to Performance Evaluation

(W0930-06-39) Can Molecular Descriptors Drive Nanosuspension Innovation? Leveraging Machine Learning and AI to Predict the Particle Size

(M0930-06-39) Developing Multiple Strengths of Controlled Release Tablet Formulations

(T0930-06-39) Stability of Nifedipine Amorphous Solid Dispersions (ASDs) with Low Drug Loading in Rodent Chow

(T0930-06-40) Extra-Large Spray-Freeze-Dried Particles Achieve Significant Salbutamol Fine Particle Fraction for Pulmonary Delivery

(W0930-07-41) Analysis of the API Sustained-Release Mechanism of Hyaluronic Acid Nanogel (HA nanogel) Formulation

(M0930-07-42) Beyond Particle Size: Impact of Milling Techniques on Agglomeration Behavior and In Vitro Performance of Long-Acting Injectable Suspensions

(W0930-07-42) Development of a Drug-Eluting, 3D-Printed, Injectable Intraocular Lens for Glaucoma Treatment

(W0930-07-43) 3D-Printed Microfluidic vs Conventional Fabrication of P(DMAEMA-co-SMA)-Based Lipopolyplexes: A Comparative Study of Stability, Morphology and Cytotoxicity

(T0930-07-43) Voriconazole Nanosuspension-Loaded Microneedle Patch for Fungal Keratitis

(T0930-07-44) In Vitro Deposition Studies of Microparticulate Nasal Powders

(W0930-07-44) Spray-Dried Solid Dispersions of Edaravone for Enhanced Oral Delivery

(W0930-07-45) Development of a High Drug-Loaded Sustained Release Tablet of a Highly Water-Soluble Drug Using Kollidon® SR via Twin Screw Melt Granulation

(M0930-07-45) Predictive Stability Modeling of Softgels

(T0930-07-46) Biodegradable, Hormone-Free Thermoresponsive Vaginal Gels for On-Demand Contraception Using Low-pH Block Copolymer Systems

(M0930-07-46) Enhancing the Solubility of Sotorasib (AMG-510) with the Acid-Base Supersolubilization (ABS) Approach to Formulate ASDs by Hot Melt Extrusion

(M0930-07-47) In Situ Measurement of Multiple Chemical Compound Species in Dissolution Medium Using a Fiber Optics UV Spectrometer

(W0930-07-47) The Importance of Microcrystalline Cellulose Selection for Fluid Bed Wet Granulation

(W0930-08-49) Engineering Biodegradable Polymer–Drug Conjugates for Precision Oncology Nanomedicine

(M0930-08-50) Engineering Stimuli-Responsive Hierarchical Nanogels for Programmable Pulsatile Oral Vaccine Delivery

(W0930-08-50) Formulation Process Development of a Novel Combination Analgesic Based on Risk Assessment (RA) and Design of Experiments (DoE)

(T0930-08-50) Polymer Coated Solid Injectable Dispersions for Long-Acting Delivery of Tenofovir Alafenamide

(M0930-08-51) Design and Evaluation of 3D Printed Hydrophilic Transdermal Films of Pramipexole Dihydrochloride Using PVA Variants

(T0930-08-52) Biorelevant Imaging and Formulation-Specific Release Prediction for the Rapid Assessment of Long-Acting Injectables

(M0930-08-52) Improving Solubility of Poorly Soluble Active Pharmaceutical Ingredients:The Impact of Plasticizers in Melt-Based Amorphous Solid Dispersions with Polyvinyl Alcohol

(W0930-08-52) Influence of Curing Conditions on the Functional Integrity of Aqueous and Solvent-Based Approaches for Enteric Coating

(W0930-08-53) AI/ML Model Informed Early-Stage Drug Development

(T0930-08-53) Modeling Metamorphosis: Advancing Dermal PBPK Modeling – A Metronidazole Case Study

(M0930-08-53) Troubleshooting a Dose Proportional Tablet Formulation

(T0930-08-54) Design of Dissolving Microneedles Based on Amorphous Salt Formation for Controlled Drug Release

(M0930-08-54) Development of a Patient Friendly, Pediatric Formulation of Xalkori Leveraging a Multiparticulate Formulation Approach and Quality By Design Principles

(W0930-08-54) Long Acting In Situ Forming Implants – Hydrogel Phantom Approach and Comparative In Vitro Release Studies

(W0930-09-56) Assessing the Performance of Lipids as Surfactants to Enhance the Release Profile of a Model BCS Class IV Compound from Amorphous Solid Dispersions (ASDs)

(T0930-09-56) Cloudy with a Chance of Precipitation- An Investigation into Physiochemical Incompatibilities between Parabens and Polysorbate 80

(M0930-09-56) Excipient Screening of Long-Acting In Situ Forming Gels during Preclinical Formulation Development

(M0930-09-57) AI-Driven Color Selection for Highly Regulated Pharma and Nutra Markets

(T0930-09-57) Dissolution-Membrane Permeation Combined with Dissolution Imaging for Bioperformance Prediction of Amorphous Solid Dispersion Manufactured by a Novel Co-Precipitation Process

(W0930-09-57) In Vitro Bioequivalence Evaluation of Topical Creams Throughout the Product’s In-Use Shelf Life

(W0930-09-58) Evaluating the Biopredictivity and Robustness of In Vitro In Vivo Correlation (IVIVC) for Acetaminophen Absorption Using TIM Advanced In Vitro Gastrointestinal Models

(W0930-09-59) A Systematic Study of the Plasticizing Effect of Phospholipids with Various Amounts of Hydrogenated Phosphatidylcholine

(T0930-09-59) Population Balance Modeling of Aggregation in Long-Acting Injectable Formulations Integrated with PBPK

(M0930-09-59) Topical MEK Inhibitor Formulations Suppress HPV E6/E7 Expression and Promote Tumor Regression in Preclinical Models

(M0930-09-60) Drugs as Excipients: Evaluation of Colistin, a Cationic Antimicrobial Peptide, as a Multifunctional Stabilizer of Inhalable Niclosamide Microparticles

(W0930-09-60) High Drug Load Nanocrystalline Formulations Matching the Performance of Supersaturating Amorphous Solid Dispersions and Offering Reduced Pill Burden

(T0930-09-60) Poloxamers in Continuous Melt Granulation: Dual Role as a Binder and a Solubilizer

(M0930-09-61) Effective Aerosol Delivery of Dry Powder Inhalers during Mechanical Ventilation: Role of Humidity and Circuit Parameters

(T0930-09-61) Enhancing the Tabletability of Fenofibrate-HPMCAS Amorphous Solid Dispersions Using Kollitab® DC 87 L: A Multifunctional Excipient Approach for Direct Compression

(T1030-06-34) Biogenic Isatin Derivative (TM-19) Loaded Green Silver Nanoparticles Using Citrus Fruit Peel in the Treatment of Fungal Infection: In Vitro and Ex Vivo Studies

(M1030-06-34) Investigating Bioequivalence of Antimalarial Formulations Using In Vitro and In Silico Biopharmaceutics Tools

(T1030-06-35) Design and Development of Dose-Flexible Formulation of Pyrimethamine Using Binder Jet 3D Printing

(W1030-06-35) Development of Terminalia avicennioides Extract-Hyaluronic Acid Hydrogel Formulation for the Treatment of Methicillin-Resistant MStaphylococcus aureus in Wound Infections

(M1030-06-36) Creating an Ultra-Long-Acting Parenteral Atovaquone Prodrug Nanosuspension for Malaria Chemoprophylaxis

(T1030-06-36) Development of Thermoresponsive Tacrolimus Loaded Nanoemulgel for Localized Immunomodulation in Psoriasis

(W1030-06-36) Engineered Oral Nanoparticle Delivery for Metronomic Chemotherapy in a PTX-Resistant Ovarian Cancer Mouse Model: Investigating the Efficacy and Off-target Effects

(W1030-06-37) Investigating the Physical Stability of GENE-A Dry Powder for Inhalation Using Solid-State Techniques

(M1030-06-37) Predicting Drug Release from EVA-Based Long-Acting Implants: Mechanisms, Modeling, and Simulation of Drug Release

(W1030-06-38) Development of Drug in Adhesive-Based Transdermal Patch of Pelubiprofen for Arthritis Treatment

(M1030-06-39) Impact of Polyethylene Glycol Polymer in the Development of Long-Acting Injectable Suspensions

(M1030-06-40) Development and Validation of UPLC Method for Digoxin and Degradants and It's Application to Assess the Effect of Process Variables on Quality Attributes of Digoxin Formulations

(T1030-07-41) A Targeted Drug Delivery System for the Treatment of Colorectal Cancer

(M1030-07-42) Optimization of Perfluorocarbon-Based Oxygen Carriers for Machine Perfusion with Controllable Oxygen Release

(T1030-07-43) Cyclosporine A Nanoparticles Combined with Urolithin A Mitigate Osteoporosis in Ovariectomized MRL/lpr Mice

(M1030-07-43) Long-Term Release Kinetics and Characterizations of Episcleral Silicone Implants for Anterior Segment Ocular Delivery of Ketotifen Fumarate and Cyclosporine A

(W1030-07-44) Investigating the Role of Surfactants and pH Modifiers in Overcoming pH-Dependent Solubility Limitations of Febuxostat, a Weakly Acidic and Poorly Soluble Drug, via Hot-Melt Extrusion

(M1030-07-45) Effect of Drug Properties on the Formation of Amorphous Solid Dispersion

(T1030-07-45) NMR Analysis of Molecular Interactions of Polyoxyethylated Amphiphiles for Solid Micellar-Size Nanoparticles: Probing into the Mechanism of Anti-Dilution Properties

(M1030-07-46) Leveraging Carnitine-Functionalized Lipid Nanocarrier-Based Targeted Delivery of A1874 PROTAC for Glioblastoma

(T1030-07-46) Sustained Release of a Pan-RAF–MEK Molecular-Glue (NST-628): A New Strategy for Long-Acting Cancer Therapy

(M1030-07-47) A Data-Efficient Approach to Design Stable Solid-State Lipid Nanoparticles for Microneedle Application

(W1030-08-49) Solubility and Dissolution Improvement of Gliclazide through Complex formation with Meglumine

(W1030-08-50) Development of Delayed Release Capsule Formulations of a Nutraceutical Active Compound Using Hydrophilic Matrix Systems

(T1030-08-50) Development of Lumefantrine Amorphous Solid Dispersion Using Vertical Hot Melt Extrusion

(M1030-08-50) Enhancing Capsule Swallowability via Double-Layer Design for Superior Glide in Wet Conditions

(W1030-08-52) Optimization of Roller Compaction Process Parameters and Roller Design of Poorly Flowing Powder Blend

(M1030-08-52) Revolutionizing Chewable Tablet Fabrication: A Green, Continuous Approach via Hot Melt Extrusion Integrated with Direct Extrusion-Based 3D Printing

(T1030-08-52) Solid-State Characterization of Crinone^® (Progesterone Vaginal Gel): Microscopy, X-Ray Diffraction, and Thermal Behavior

(T1030-08-53) An Advanced Drug Delivery System for Enhancing Enteric Resistance and pH-Triggered Drug Release in the Duodenum

(M1030-08-53) Evaluation of Talc Alternative for EUDRAGIT^® E PO-Based Coatings

(W1030-08-53) Evaluation of Titanium Dioxide Alternative in Polymethacrylate (EUDRAGIT^® E PO) Based Coatings

(M1030-08-54) ASAPprime®: A Fast-Track Insight to the Stability of Tablets Impacted by Coating

(W1030-08-54) Setting the Benchmark: Enhanced Purification of Polyoxyl 35 Castor Oil Using a Novel In-House Adsorbent System

(W1030-09-56) Investigating the Impact of Variation in Carbomer Homopolymer Type C (Carbopol® 980) concentration on Diclofenac Sodium Gels’ Microstructure and Skin Permeation

(M1030-09-56) Personalized 3D-Printed Tablets for Diabetes and Related Complications: Design, Optimization, and Evaluation

(T1030-09-56) Split Decisions: Tracking Preservative Partitioning in Cream Formulations

(T1030-09-57) Formulation Development of Immediate Release Ilaprazole–Antacid Fixed-Dose Combination Tablets and Pharmacokinetic Evaluation in Beagle Dogs

(W1030-09-57) Improving PROTAC Dissolution via an Ionic Liquid API Approach with Enhanced Solid Handling

(M1030-09-57) Investigation of Nintedanib Formulation Development: Systematic Screening from pH Solubility Assessment to Sodium Fatty Acid Salt-Polymer Optimization

(M1030-09-59) Evaluation of Spray Dried and Nanomilled Formulations on Pharmacokinetics Using Predictive Modeling

(W1030-09-59) Investigation of Advanced Fattigation-Platform Using PLGA-Cystamine-Fatty Acid Conjugates for Effective Tucatinib Delivery

(T1030-09-59) Spray-Dried Amorphous Solid Dispersions of Celecoxib-PVPVA64-SBEβCD Ternary Complexes: Preparation, Flory Huggins Interaction Parameters and Dissolution Enhancements

(W1030-09-60) Effect of Polymer Architecture on Crystal Growth in Amorphous Nifedipine: Bottlebrush vs. Linear Polymers PEGs

(M1030-09-60) Influence of the Biorelevant Media on the Solubility of Benzthiazide, Isoxicam, and Piroxicam in the Presence of Several Excipients

(T1030-09-60) Key Materials Attributes, Process Challenges and Fast-Track Stability Evaluation in Designing the Immediate-Release Formulation for Alzheimer’s and Parkinson’s Disease

(M1030-09-61) Lyotropic Liquid Crystalline Nanoparticles for Gene Delivery: Influence of Composition on Physicochemical Properties, Cellular Uptake, and DNA Encapsulation

(T1030-09-61) Quantitative Differences in Carbomer Homopolymer Type B and Its Effect on the Structural and Permeation Characteristics of Diclofenac Sodium Topical Gels

(W1030-09-61) Study on Solid Dispersion by High Shear Granulation Using HPMC and HPMCAS as Carrier

(T1130-06-34) Mitochondria-Targeted Delivery of Metabolic Modulators to Tumor-Associated Macrophages for Immunotherapy

(M1130-06-34) The Particle Drifting Effect In Vivo: Impact of Dose and Animal Species

(W1130-06-34) Topical Liposomes for the Treatment of Fuchs Endothelial Corneal Dystrophy (FECD) Obviating the Need for Surgery

(T1130-06-35) Dual-Action Nanotherapy Reduces Ocular Inflammation in Mice with Systemic LPS-Induced Uveitis

(T1130-06-36) Aging of Viscoelastic Organogels Designed as Platforms for the Prevention of Bovine Mastitis

(W1130-06-36) Investigation on Role of Penetration Enhancers to Improve Topical Permeability of Clotrimazole

(T1130-06-37) Abacavir/Lamivudine Nanobased Fluid Gel System for Paediatric Antiretroviral Therapy

(W1130-06-37) Data-Driven Formulation of Solid Oral Dosage Forms: Computational Modeling to Experimental Validation Using ZoomLab^TM

(M1130-06-37) Revolutionizing Women’s Health by Enabling the Rational Development of Long-Acting Contraceptive Levonorgestrel Intrauterine Systems

(T1130-06-38) Achieving Sustained Supersaturation of Poorly Soluble Naringenin through Cocrystal Engineering

(W1130-06-38) Formulation of a Teixobactin-Lipopeptide Hybrid as an Inhalable Dry Powder for the Treatment of Pulmonary Pan-Drug Resistant Bacterial Infections

(M1130-06-38) Real-Time PAT Monitoring of Coating Process in the Design and Optimization of a Dose-Flexible Tolfenamic Acid Dosage Form for Cancer Indication

(M1130-06-39) Biosustane as a Novel Oral Excipient for Solid Dosage Forms – Formulation Development, Characterization, and IVIVC Prediction

(W1130-06-39) Development of In Vitro Release Testing and In Vitro Permeation Testing Methods to Study the Impact of Quantitative Differences in Carbomer on the Performance of Diclofenac Sodium Topical Gels

(T1130-06-39) Transdermal Bilayer Microneedle Array Patches (MAP) for Pediatric HIV Therapy: Investigating Wear Time and Islatravir Delivery Efficiency

(T1130-06-40) Extending the Tabletability Mixture Model to Poorly Compressible APIs

(M1130-07-41) Development and Verification of Novel Agarose Gel Based Dialysis Cassette System as an In Vitro Release Model for Long-Acting Injectable Formulations

(W1130-07-41) Inhale It: Heterologous Intranasal Delivery of a SARS-CoV-2 Microparticle Vaccine

(T1130-07-41) Intratumoral Delivery of Lapatinib via pH-Responsive Liposomes Embedded in a Thermosensitive In Situ Hydrogel: A Potential Chemotherapeutic Modality for Breast Cancer

(M1130-07-42) Prevention of Lung Cancer Using Bio-Enhanced Sulfasalazine and Disulfiram Nano Self-Emulsifying Drug Delivery System Platform: Formulation Development, Pharmacokinetics, and Biodistribution Study

(T1130-07-42) Triple Functionalized Liposomes for Improved Penetration and Targeting of VGF Gene Across BBB in Alzheimer's disease Management

(M1130-07-43) Formulation Development of Oral CBD-Loaded SEDDS with Optimized Dissolution and Digestive Performance

(T1130-07-43) Vortioxetine-Loaded Liposomes: A Repurposed Approach for Glioblastoma Therapeutics

(W1130-07-44) Bioadhesive-Drug Powder Mixtures for Improved Local Delivery to the Nasal Mucosa

(T1130-07-45) Formulation of Acetaminophen Chewable Tablets Using Carrageenan

(M1130-07-45) Optimizing Solution Performance Through Solid Form Diversity – A Study of Naringenin:Tetramethyl Pyrazine Cocrystals

(W1130-07-45) Solubility Enhancement of Ibuprofen via Crystalline Solid Dispersions: A Comparative Study of Carriers and Optimization Using DoE

(W1130-07-46) Evaluation of Stability and Functional Packaging Effectiveness for Ferrous Ascorbate Tablets Coated with Aqueous Moisture Barrier Film Coating Formulation

(T1130-07-46) ZoomLab^®-Enabled Development of Directly Compressible Solid Dosage Forms with a Novel Co-processed Excipient

(M1130-07-47) Downstream Processing of Spray Dried Amorphous Solid Dispersions via Roller Compaction

(W1130-08-49) Liposomal Co-delivery of Luteolin and Piperine for Enhanced Lung Cancer Cell Death: In Vitro Characterization and Anticancer Activity

(W1130-08-50) Development of Long-Acting Injectable Formulations of Next Generation Diarylquinolines for Preventive Therapy of Tuberculosis Infection

(T1130-08-50) Influence of Nanoparticle Composition on the Dutasteride Follicular Accumulation

(M1130-08-50) Personalized Drug Delivery via 3D-Printed Tablets: Optimizing Patient-Specific Release Kinetics Using a Central Composite Design

(M1130-08-52) Development of Organic Solvent-Free Amorphous Solid Dispersions of Felodipine with PEGs via Supercritical CO₂ Processing: A Green Strategy for Enhanced Dissolution and ODT Formulation

(T1130-08-52) Identification of Formulation Design Space for Quetiapine Fumarate Extended-Release Tablets across Strengths

(W1130-08-52) Optimizing Compression Pressure for Disintegration Efficiency in ODTs: A Formulation Strategy Using F-MELT^® Platform Technology

(W1130-08-53) Alcohol Resistant Extended Release Multiparticulates Based on EUDRAGIT® NM 30 D

(M1130-08-53) Antioxidant Inclusion for the Preservation of Physical, Chemical, and Functional Properties of Polymeric Surfactants and Stabilizers during Terminal Sterilization (Gamma Irradiation)

(T1130-08-53) Miniaturized Screening Tool for Evaluating Solubility Enhancement Across Multiple Active Pharmaceutical Ingredients

(W1130-08-54) Feasibility Screening of Adsorption-Based Amorphous Solid Dispersions for Mefloquine HCl

(M1130-08-54) Investigating the Cause of Dissolution Failure of a Highly Soluble Pharmaceutical Salt Form of a Molecule

(T1130-08-54) Quinic Acid and ATP-Dual Ligand Nanoparticles for Systemic Cancer Chemoimmunotherapy

(W1130-09-56) Localized Immunomodulation Strategy for Enhanced Allogenic Cells Integration in Implantable Devices

(M1130-09-56) Nanoparticle Corona Composition Differs Due to Lifestyle Factors

(T1130-09-56) Nicotine Hydrogen Tartrate Containing Fast Dissolving Films: Formulation and In Vitro Evaluation

(M1130-09-57) Development of a Gefitinib-Loaded Niosomal Formulation for Pulmonary Delivery via Nebulization

(T1130-09-57) Enhanced Topical Delivery of Metronidazole: A Comparative Study of Single and Binary Solvent Systems

(W1130-09-57) Modelling Twin Screw Wet Granulation Process: Impact of L-HPC on Granules and Tablet Properties

(T1130-09-59) Controlling Nitrite Pathways in Drug Manufacturing to Prevent Nitrosamine Impurities: An Active Packaging-Based Approach

(M1130-09-59) Investigating the Release Profiles of Mesalamine Matrix Granules: EUDRAGIT® NM 40 D vs. EUDRAGIT® NE 40 D

(W1130-09-59) Low Molecular Weight Hydroxypropyl Cellulose as a Novel Protein Stabilizer for Parenteral Pharmaceuticals

(W1130-09-60) Development and Clinical Evaluation of a Dexmedetomidine Sublingual/Buccal Film Using MicroDep Technology: A Rapid-Absorbing High-Bioavailability Dosage Form

(M1130-09-60) Development of a Quantitative Method for Formulation Microenvironmental pH Assessment

(T1130-09-60) Tailoring Polyester Topologies for Efficient Oral Drug Delivery Systems

(W1130-09-61) Liver Targeting Lipid Nanoparticle for Gene Delivery by Click Reaction Modification

(M1130-09-61) Small-Angle X-Ray Scattering Analysis Reveals the Internal Structure of Lyotropic Liquid Crystalline Nanoparticles Encapsulating DNA

(T1130-09-61) Stability Evaluation of 4-Phenylbutyric Acid-Loaded Micro/Nano-Particulate Formulations for Topical Delivery Against Chemical Warfare Agent-Induced Skin Injury Using ICH Accelerated and Refrigerated Conditions

(W1230-06-34) Optimizing Skincare with a Multifunctional Approach: Development of a Facial Booster Microemulsion Using Box-Behnken Design

(W1230-06-35) Freeze-Dried Self-Microemulsifying Drug Delivery Systems and Lipidic Nanoparticles for Enhancing Oral Delivery of Cannabidiol

(T1230-06-35) Lectin Conjugated Liposome Nanocarriers for Targeted Bladder Cancer Therapy

(W1230-06-36) Adhesive Insights: Evaluating Mucoadhesion Across Various Polymers in Gel Formulations

(T1230-06-36) Scalable Theranostic Nanoemulsion for Sustained Non-opioid Analgesia: Modulating Macrophage Dynamics in Peripheral Nerve Injury

(M1230-06-37) Co-delivery of Paclitaxel with Adavosertib Encapsulated in Liposome for the Treatment of Ovarian Cancer

(W1230-06-37) Comparative Evaluation of Mucoadhesive Polymers Performance in Topical, Nasal, and Buccal Gel Formulations: Impact on Drug Product Physical Property, Behavior, and Patient Acceptability

(M1230-06-38) Improving Oral Bioavailability of Therapeutic Peptides with Lipid-Based Formulations and Ready-to-Use Enteric Capsules

(T1230-06-38) Kolliphor® P407-CPBA Functionalized PLGA Nanoparticles for Co-Delivery of Sorafenib and Venetoclax: A Synergistic Strategy Targeting Ferroptosis and Apoptosis in Breast Cancer

(M1230-06-39) A Breakthrough Predictive Model for Rapid and Accurate Solubility Parameter Prediction of Lipids for Lipid-Based Drug Delivery Systems

(W1230-06-39) Development of Sustained Release Isoniazid Formulation Using Twin Screw Melt Granulation

(T1230-06-39) Understanding the Interplay between Formulation and Process Variables to Fabricate Combination Printlets of Lamivudine and Tenofovir Disoproxil Fumarate for Pediatric Populations

(M1230-06-40) Leveraging the Digital Tool HyperStart C2C for the Development of Low Dose API Formulation and Comparative Analysis of Tablet Coatings

(T1230-06-40) Mechanism of Punch Sticking Induced by a Lubricant: Hydrogenated Vegetable Oil

(T1230-07-41) Development of 3D-Printed Chitosan/P-Coumaric Acid Scaffolds for Wound Healing: Antibacterial Properties and Drug Release Kinetics

(M1230-07-41) Mass Transport Analysis of the Particle Drifting Effect in a Biphasic Diffusion Apparatus

(W1230-07-41) Mesenchymal Stem Cell Derived Exosomes as Nanocarriers for Paclitaxel in Pancreatic Ductal Adenocarcinoma (PDAC) Treatment

(W1230-07-42) 3D Printed Ileum Targeted Tablet for the Treatment of IgA Nephropathy

(M1230-07-42) Myeloid Targeted Disulfide Lipid Nanoparticle with Enhanced Endosomal Escape Improves HIV-1 Excision

(M1230-07-43) Development and Evaluation of 2% (w/w) Apremilast Ointment for Psoriasis Management

(W1230-07-43) Development and Optimization of Curcumin-Loaded Polycaprolactone Nanoparticles Using Smart Technology

(M1230-07-44) Development of Directly Compressible Formulation of High Dose Calcium Citrate Tablets using Novel Clean Label Lubricant

(W1230-07-44) Process Optimization for Benzoic Acid Spherical Agglomeration: Bridging Liquid Solubility and Supersaturation of Primary Crystallization

(W1230-07-45) Comprehensive Design and Characterization of pH-Gradient-Loaded Donkey-Milk Exosomes for Oral Octreotide Delivery: A Bench-to-In Silico Roadmap

(T1230-07-45) Double RSM Design QbD Optimization of Emulsomal Gel

(T1230-07-46) Design and Optimization of Cannabidiol SEDDS Using Response Surface Methodology for Improved Drug Release and Stability

(M1230-07-46) Machine Learning Predicts Drug Release Profiles Based on Tablets’ Formulations

(M1230-07-47) Programmable Delayed-Release Container System (PDRCS) for Chronopharmaceutical Drug Delivery: Application to Addison’s Disease

(T1230-07-47) The Combination Use of Microcrystalline Cellulose and Lactose in Direct Compression

(W1230-08-49) Influence of Excipients on Interaction of Actives with the TR146 Model

(T1230-08-50) Development of a Novel Antimicrobial Gel for the Treatment of Endodontic Disinfection

(W1230-08-50) Preclinical Development of a Long-Acting Injectable Formulation of Rifapentine from High Throughput Screening through to a GLP-Toxicology Study

(M1230-08-50) Predicting Lung Dose and Asthma Control from Real-World Dry Powder Inhaler Use

(T1230-08-51) Establish a Mucosa-Mimicking In Vitro Permeation Model for Evaluating Mucoadhesive Formulations

(T1230-08-52) Lipidation of Kv1.3 Blocking Peptide HsTX1[R14A] Modulates Its Pharmacokinetics and Biodistribution to Target Tissues

(M1230-08-52) Potential of Ultra Fine Bubbles to Enhance Insulin Membrane Permeability

(W1230-08-52) Testing Formulation Effects of Itraconazole in a Miniaturized Precipitation Set-Up

(M1230-08-53) Impact of Porosity on Drug Release from PLGA Microspheres

(T1230-08-53) Investigation of the Internal Porosity and Drug Release Profile of Screw-Based 3D-Printed Bupropion Tablets

(W1230-08-53) Surelease^® Encapsulated Caffeine for Gummies

(M1230-08-54) Design of a Sprayable Powder Formulation Containing Choline-Maleic Acid Ionic Liquid in Porous Silica for Intranasal Delivery

(T1230-08-54) Enhancing Patient Experience in Topical Formulations: A Sensory-Based Strategy Using Rheology Modifiers and Emollients

(W1230-08-54) Overcoming Flow, Blend Uniformity and Direct Compression Tabletability Challenges in Micronized APIs Through Use of Multi-Functional Excipients

(W1230-09-56) Application of Precipitation Inhibitors in Lipid-Based Simvastatin Formulations to Prepare Simvastatin Amorphous Granules

(T1230-09-56) Challenges in the Development of Polycaprolactone Microparticles for H₂S Donor Encapsulation Using Coacervation

(M1230-09-56) Enhancing Lipid Nanoparticles Shelf Life with a Vitamin A Derivative

(T1230-09-57) Application of X-Ray CT Scan and Material Profiling to Evaluate Tableting Performance of Kollitab™ DC 87 L

(W1230-09-57) Innovative Formulation Strategies for orodispersible Loratadine Dosage Forms

(M1230-09-57) Optimization of Nifedipine Tablets with OROS Technology for Controlled Drug Release

(W1230-09-59) Application of Novel Partially Pregelatinized Cassava [tapioca] Starch as Substitute Filler-Diluent to Lactose in Personalized Substance-Abuse Therapy for Lactose Intolerant Population

(M1230-09-59) Investigation of Poly(meth)Acrylate-Based Technology and Enteric Polymers for Fast Duodenal Release

(T1230-09-59) Risk Mitigation of Nitrosamine Impurities in Drug Products Containing Secondary Amine APIs Through Excipient Nitrite Control

(W1230-09-60) A Preclinical Method to Quantify Complex Formulation Interactions with Serum Proteins and Target Tissues

(T1230-09-60) Development of Long-Acting Griseofulvin Formulations for Local Treatment of Ocular Neovascularization

(M1230-09-60) Predicting the Stability of Lyophilized Formulations Containing a Monoclonal Antibody and Sucrose/Trehalose Using Solid-State NMR Spectroscopy

(W1230-09-61) A Mutli-Mechanistic Three Polymer In Situ Gelling Ocular Drug Delivery Vehicle: Optimization under a DOE Strategy

(M1230-09-61) Careful Management of the Salt Disproportionation Risk of an In-House Developed Mono-Tartrate Salt (Compound 1)

(T1230-09-61) Physiologically Based Pharmacokinetic Simulations Using Transdermal Compartmental Absorption and Transit Model (TCAT) for RLS-1496 Dermal Preparations

(M1330-06-34) Approaches toward Nanostructured-Lipid Carriers (NLCs) for Disulfiram Delivery

(T1330-06-34) Design and Evaluation of Panobinostat-Loaded Albumin Nanocarriers for Pancreatic Tumor Treatment

(M1330-06-35) Brain-Targeted Delivery of Plasmid VGF through Trifunctionalized Liposomes for the Management of Alzheimer’s Disease

(T1330-06-35) Transdermal Administration of Rivastigmine Using Hydrogel-Forming Microneedles as a Potential Treatment for Alzheimer’s disease

(M1330-06-36) Exploiting Redox and Lipid Metabolic Vulnerabilities via Albumin-Encapsulated Oxaliplatin–Oleic Acid Prodrug for the Management of Triple-Negative Breast Cancer

(M1330-06-38) Optimization of Thermoresponsive SNEDDS Formulation Loaded with Dapagliflozin Using Box-Behnken Design Approach: Overcome Manufacturing Challenges

(T1330-06-38) Synergistic Effects of Fatty Acid Salt and Non-ionic Surfactant for Enhanced Solubilization and Amorphization of Sorafenib in Polymeric Matrix

(M1330-06-39) Brexanolone Inclusion Complexes with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies

(T1330-06-39) Pea Starch as an Environmentally Sustainable Solution in Pharmaceutical Film Coating Applications Using the ReadiLYCOAT^® System

(T1330-07-41) From Pill to Patch: Transforming Plasmodium vivax Malaria Therapy with Hydrogel Microarray Patches

(M1330-07-41) Impact of Gastric Phase Simulation on the In Vitro Lipolysis of Lipid-Based Formulations Containing Ticagrelor or Fenofibrate

(M1330-07-42) Development of a Prototype Layer for a Multi-Layer Smart Bandage: Fabrication of Biopolymer-Based Hydrogels with Anti-Inflammatory and Antimicrobial Properties via 3D Bioprinting

(M1330-07-43) Biodegradable Nanoparticles for the Treatment of Triple-Negative Breast Cancer Fabricated by the Dispersion Polymerization Technique

(M1330-07-44) Patient In-Use Stability of FDA-Approved Delayed-Release Products of Divalproex

(M1330-07-45) Formulation of Rapidly Dissolving Amorphous Solid Dispersion of Posaconazole, an Extremely Water-Insoluble Basic Drug via Hot-Melt Extrusion by Applying Acid-Base Supersolubilization Principle

(T1330-07-45) Tailored Sodium Alginate-Based Hydrogel System for Submucosal Lifting: A Breakthrough in Endoscopic Mucosal Resection and Submucosal Dissection

(M1330-07-46) Development and In Vitro Evaluation of Modified Release Bupropion Hydrochloride Tablets for Enhanced Drug Delivery

(T1330-07-47) Fast-Dissolving Oral SMEDDS Films: A Novel Platform for Enhanced Delivery of Vitamin D3

(M1330-07-47) Tabletability Flip in Dry Granulated Systems

(T1330-08-48) Investigation of the Transdermal Delivery of Mangiferin Loaded Starch Nanoparticles

(M1330-08-50) Improving Intranasal Naloxone Delivery Using Excipients in a Tissue Model

(T1330-08-50) Thermo-Responsive F127-BUM as a Platform for Drug Delivery Innovation

(T1330-08-52) Developing a Minitablet Formulation for an NCE to Enable Dose and Administration Flexibility in Pediatric Clinical Trials

(M1330-08-53) Machine Learning and Automation Accelerate Formulation Development by Enabling Fast High-Throughput Screening for Long-Acting Injectable Drug Formulations

(T1330-08-53) Optimization of Tablet Coating Composition and Weight Gain for Moisture Protection Using Optimal Combined Design of Experiments (DOE)

(M1330-08-54) Critical Insights into High Drug Load Amorphous Formulations: Challenges and Advanced Techniques

(T1330-08-54) Mucoadhesive Buccal Tablets: A Patient-Centric Approach to Oral Mucosal Drug Delivery

(M1330-09-56) Neratinib Nanocrystals, Preparation, Characterization and In Vitro Evaluation Against Triple-Negative Breast Cancer

(T1330-09-56) Sodium Sulfide Nonahydrate (Na₂S·9H₂O), a Hydrogen Sulfide (H₂S) Donor and Its Solid-State Characterization

(M1330-09-57) Dissolution Enhancement Technique of Amorphous Solid Dispersions by External Addition of HPMCAS

(T1330-09-57) Efficient Manufacturing of Omeprazole Modified-Release Pellets Using Talc-Free Aqueous Coating System

(M1330-09-58) Berberine Hydrochloride Amorphous Solid Dispersion via Hot-Melt Extrusion for Taste Masking and Bioavailability Enhancement

(M1330-09-59) Development of Rifaximin Soluble Solid Dispersion (SSD): I. Solubility and Dissolution Advantage Over Commercially Available Xifaxan 550 mg Tablet

(T1330-09-59) Low-Substituted Hydroxypropyl Cellulose (L-HPC^®) Improves the Flowability and Compressibility of Acetaminophen via Twin-Screw Wet Granulation (TSWG): Comparison with Ac-Di-Sol^® and Kollidon^® CL

(M1330-09-60) Sustainability Considerations in Patient-Centric Formulation Selection

(T1330-09-60) Use of PBBM-PBPK to Predict Mesalamine Delayed-Release Oral Drug Products Performance in Both Healthy and Disease Physiologies

(T1330-09-61) Hollow Microneedle-Based Delivery of Voriconazole Ionic Liquid for Nail Fungal Infections

(M1330-09-61) Homogenization Process Conditions Affect the Chemical Stability of Polysorbate 80 and Globule Size Distribution of Castor Oil Emulsion

(M1430-06-35) Sustained Transdermal Delivery of Ropinirole Hydrochloride via Monolayer Dissolving Microneedle Array Patches

(T1430-06-36) Exploration of FDM 3D-Printed Multi-Compartment Drug Delivery Devices: Structural Modulation of Release Kinetics for Personalized Therapy

(M1430-06-36) Self-Micellizing Dry Powder Inhaler System for Cyclosporine A Using Sodium Stearate

(T1430-06-37) An Inhalable Spray Dried Powder of Linezolid and Antimicrobial Peptide for Tuberculosis Treatment

(T1430-06-38) A Computational Approach for Studying Drug Delivery Process Through Multilayered Drug Delivery Devices

(M1430-06-38) Effects of Sodium Alginate Properties on Mucoadhesion and Mucociliary Clearance

(M1430-06-39) Development of a Cannabidiol Dry Powder Inhaler Using Sodium Stearate: Enhancement of Aerosol Performance and Stability

(T1430-06-39) Effect of Formulation and Process Parameters on Fenofibrate Impregnation in Mesoporous Neusilin Particles

(T1430-06-40) Design and Evaluation of a Taste-Masked Sustained Release Effervescent Formulation of Caffeine

(M1430-06-40) Determination of Chemical Species Compound Concentrations (Free Form, Ion) during a Membrane Permeation Test Using Simulated Intestinal Fluid

(T1430-07-41) MMP-Sensitive Nanomedicine for Macrophage-Targeted Delivery of Coenzyme Q10

(M1430-07-42) Ripasudil Liposomes for the Treatment of a Polygenic Corneal Disease

(T1430-07-42) The Influence of Different HPMCAS Grades for Preparation of Enteric Capsules Investigated by MRI in Human Volunteers

(T1430-07-43) Sandwiched Nanofiber Sheets and Hybrid Gel for Localized and Prolonged Management of Cervical Cancer

(M1430-07-44) Exploring Powder Discharge-Based KinetiSol. a Modified KinetiSol® Process for Manufacturing Dry Powders for Inhalation: A Proof of Concept

(T1430-07-45) Development of Inhalable Tadalafil Formulations for the Treatment of Pulmonary Hypertension

(T1430-07-46) Advanced Characterization of Injectafer^®: Carboxymaltose Structure, Iron Core Structure, and Interaction of Carboxymaltose with Iron Core

(M1430-07-46) Formulation of a Hydrophilic Transdermal Patch for Combined Delivery of Sumatriptan and Metoclopramide in Migraine Therapy

(M1430-07-47) Impact of High Pressure on Structure and Thermal Properties of Amorphous Pharmaceuticals and Biopharmaceuticals

(T1430-07-47) Probing Dynamics of Amorphous Solid Dispersions Using Carboxylic Acid Dimer Formation

(T1430-08-50) Developments of Advanced Military Measure of Olfaction (AMMO) as an Indicator of Traumatic Brain Injury (TBI) Through Sense of Smell: Solving Excipient-Active Stability Interactions

(M1430-08-50) HPC vs HPMC – A Mechanistic Investigation on Bioadhesion via Swelling and Rheological Data

(M1430-08-52) Development of an Advanced Hydrogel-Based Drug Delivery System for Enhanced Neuroprotection in Traumatic Brain Injury

(T1430-08-52) Overcoming Formulation Challenges of an Unstable Amorphous Prodrug by API Sparing and Enteric Coating Approaches

(M1430-08-53) Development of Pediatric Immediate Release Mini-Tablet Formulation for a Novel FGFR Inhibitor Using Direct Compression and Functional Coating

(T1430-08-53) Development of Rifaximin Soluble Solid Dispersion (SSD). III XRPD Method Development to Evaluate % Crystallinity and Amorphousness

(T1430-08-54) Influence of Particle Morphology on Amorphous Solid Dispersion Drug Product Design

(M1430-08-54) Solubility Enhancement Using Anionic Poly(meth)Acrylate-Based Solid Dispersions

(M1430-09-56) Application of the Hot Melt Extrusion Risk Assessment Classification System (HCS) to a Poor Glass Forming, High Melting Point Drug

(T1430-09-56) Impact of Dosage Form on Drug Release from Danazol-ASD at LoC: A Comparative Study

(M1430-09-57) Engineering of Docetaxel Smart Crystalline Solid Dispersion for Prostate Cancer Therapy

(T1430-09-57) From Miscibility Modeling to Performance: Developing Stable ASD Granules of Nifedipine Using Poloxamer and Copovidone

(M1430-09-59) Control of Particle Size, Distribution and Modality of a Rifapentine Solid Drug Nanoparticle Formulation through Modified Formulation Approaches

(T1430-09-59) Glyco-Conjugated Mesoporous Silica Nanoparticles Enhance Meropenem Delivery against Multidrug-Resistant Bacteria and Biofilms

(M1430-09-60) Assessment of Antioxidant to Prevent Degradation in Moisture-Sensitive Tablets

(T1430-09-60) Solubility Enhancement of a Poorly Water-Soluble Drug Using Hypromellose Phthalate HP-50 by the Hot Melt Extrusion Process

(M1430-09-61) Preclinical Development of Long-Acting Injectable Formulations of Glecaprevir and Pibrentasvir for Curative Treatment of Hepatitis C in Low- and Middle-Income Countries

(T1430-09-61) Rational Development of Donepezil-Curcumin Intranasal Nanotherapies for Alzheimer’s Disease

(T1530-06-34) Designing Novel Modified Release Self-Emulsifying Drug Delivery Systems (n-SNEDDS) for Nasal Delivery with Enhanced Therapeutic Outcomes

(M1530-06-34) Fluorinated Polyethylene Glycol Decorated Liposomes for Mitochondria-Targeted Delivery of Heat Shock Protein Inhibitors

(M1530-06-36) Development of Polymeric Dual-Drug Nanoformulation: Enhancing Bioavailability and Preclinical Efficacy in Diabetic Nephropathy Treatment

(T1530-06-37) Engineering Oral Tablets with Precision: A Deep Dive into SLS 3D Printing, Drug Release, and Material Characterization

(T1530-06-38) Formulation of an Antimalarial Agent (ELQ-598) as a Sustained Release Injectable

(M1530-06-38) Massing Sensitivity Index (MSI): A Practical Tool to Investigate the Robustness for a High Shear Wet Granulation Formulation and Process

(T1530-06-39) Development and Evaluation of Stable 24-Hour Sustained-Release Tablet Formulations with Alcohol-Induced Dose Dumping Prevention

(M1530-06-39) Development of a Topical Meloxicam Formulation for Enhanced Transdermal Delivery

(T1530-06-40) Application of Colloidal Microcrystalline Cellulose in Reconstitutable Suspension

(M1530-07-41) Charge-Driven Nanocomplexation of Alexidine Reduces Its In Vivo Toxicity and Facilitates Its Development as a Broad-Spectrum Antifungal Agent

(T1530-07-41) Harnessing MSCs as a Tumor-Targeted Delivery Platform for Epigenetic and Chemotherapeutic Combination Therapy in Lung Cancer

(T1530-07-42) Leveraging Plant-Derived Extracellular Vesicles for Advanced Therapeutic Applications

(T1530-07-43) Effect of Gelling Agents on the Rheological Properties of Organogels Designed for Intramammary Administration

(M1530-07-44) Development of Clotrimazole Oral Films via Hot-Melt Extrusion for Improved Pediatric and Geriatric Drug Delivery

(T1530-07-44) Highlighting the Critical Role of Capsule Selection in Capsule Dry Powder Inhalation Aerosol Performances

(M1530-07-45) Exploring Freeze-Dried Polymeric Complexes with Different Fatty Acid Salts for Enhanced Olaparib Solubility and Permeation

(T1530-07-45) HPC-CA - A Novel Cellulose Derivate for Amorphous Solid Dispersion

(M1530-07-46) Spray Drying of Poorly Water-Soluble Drugs Without any Organic Solvent Using the Acid-Base Supersolubilization (ABS) Principle

(T1530-07-47) Control Over Microparticle Size Enables Precise Modulation of the Insufflator Spray Pattern and Olfactory Deposition in a 3D-Printed Nasal Model

(M1530-07-47) Predicting the Tabletability of Powder Mixtures Lubricated with Magnesium Stearate

(T1530-08-49) Preparation and Characterization of Cocrystals and Salts of an Indole-2-Carboxamide Anti-Mycobacterial Agent

(T1530-08-50) Chemical Profiling and Single-Solvent System Effects in Topical Cimetidine Formulations

(M1530-08-50) Comparison of Colloids from HPMCAS Grades Across Physiologically Relevant Media

(T1530-08-51) Synthesis and Characterization of Biodegradable Polymer Backbone for the Development of Dual-Drug Polymer Conjugate for Pancreatic Cancer Treatment

(T1530-08-52) Development of a Gastro-Retentive Bimodal Release Bilayer Tablet to Enable Once-Daily Dosing, Fast Onset and Blunted C_max for an NCE with Short Half-Life

(M1530-08-52) Enhancing Amorphous Solid Dispersion Polymer Screening: A High-Throughput Approach with Fully Automated Sampling

(T1530-08-53) ASD Formulation to Unit Dosage Form: Integrated Drug Product Development with Dispersome

(M1530-08-53) Facilitating Robust Manufacturing of Low-Dose Oral Solid Drug Products using Directly Compressible Mannitol

(M1530-08-54) Compatibility Assessment of Ready-to-Fill Delayed Release Capsules with Self-Nanoemulsifying Drug Delivery Systems (SNEDDS)

(T1530-08-54) Modulating Precipitation of Small Molecule Drugs upon Intraperitoneal Injection Using Cyclodextrin Containing Formulations

(T1530-09-56) Antioxidant Screening for the Inhibition of N-nitroso Propranolol Formation in Solution and Solid-State

(M1530-09-56) Rational Design of Topical Semi-Solids: An All-Virtual, Inverse Design Process

(M1530-09-57) Cocrystallization: A Strategy to Tune Surface Composition and Improve Wettability of Hydrophobic Drugs

(T1530-09-57) Development of Long-Acting Bupivacaine-Loaded Multivesicular Liposomes Using Prilling Technique

(T1530-09-59) Effects of Permeation Enhancers on the Epithelial Transport and Bioavailability of the Proteolysis Targeting Chimera (PROTAC) ARV-471 in Rats

(M1530-09-59) Solid-Phase Strategy for High-Yield Diversification and Functional Evaluation of Ionizable Triazine Lipids for mRNA Delivery

(M1530-09-60) Algorithm-Based Excipient Selection for Solid Dispersion Development

(T1530-09-60) Lipid-Based Formulations: How to Predict Rat In Vivo PK Profile with In Vitro + In Silico Approach

(M1530-09-61) Development and Optimization of Liquisolid Compacts of Febuxostat Using Conventional Processing and Twin-Screw Granulation: A Comparative Study for Solubility and Dissolution Enhancement

(T1530-09-61) Hansen Solubility Parameter-Based Modeling to Improve Solubility Profiling of Challenging APIs and Accelerate Formulation Development